Loading clinical trials...
Loading clinical trials...
Development of a Novel Kidney-focused Approach to Treatment of a Patent Ductus Arteriosus (PDA) in Vulnerable Preterm Neonates - A Pilot Study
The goal of this observational study is to gather more information on kidney oxygen levels in babies with a patent ductus arteriosus (PDA), and evaluate the relationships between kidney oxygen levels, PDA status and kidney injury. Researchers will do this by looking at ultrasound images of the heart, analyzing substances in the urine, and evaluating oxygen levels in the kidneys.
Age
0 - 0 years
Sex
ALL
Healthy Volunteers
No
Meriter Hospital, Inc.
Madison, Wisconsin, United States
Start Date
December 19, 2024
Primary Completion Date
January 1, 2027
Completion Date
May 1, 2027
Last Updated
February 3, 2026
45
ESTIMATED participants
Near Infrared Spectroscopy
DEVICE
Lead Sponsor
University of Wisconsin, Madison
Collaborators
NCT05647213
NCT07042334
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions